This means that CCL2 produced by HIV-1-infected macrophages would have the capacity to recruit both monocytes and activated T cells to the site of infection, facilitate the latent infection of resting T cells, and enhance virus replication in activated T cells. The gene discussed is CCL2; the disease is disease arising from reactivation of latent virus.